Nurix Therapeutics, Inc. Revenue From Contract With Customer Excluding Assessed Tax

Quick Answer

Nurix Therapeutics, Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $83.98 million for the year ending 2025.

  • Nurix Therapeutics, Inc. showed an increase of +54.0% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
  • This data is from Nurix Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on January 28, 2026.
  • XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 4 years of available data (2022 to 2025), Nurix Therapeutics, Inc.'s Revenue From Contract With Customer Excluding Assessed Tax has grown by 117.4%.
  • Historical annual values: Fiscal year 2025: $83.98 million | Fiscal year 2024: $54.55 million | Fiscal year 2023: $76.99 million | Fiscal year 2022: $38.63 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: